{"id":"NCT02069899","sponsor":"Swedish Orphan Biovitrum","briefTitle":"A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody","officialTitle":"A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2014-08-04","primaryCompletion":"2021-05-18","completion":"2021-05-18","firstPosted":"2014-02-24","resultsPosted":"2022-06-28","lastUpdate":"2022-06-28"},"enrollment":58,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Hemophagocytic Lymphohistiocytosis"],"interventions":[{"type":"DRUG","name":"Emapalumab","otherNames":["NI-0501"]}],"arms":[{"label":"Enrolled-04 Cohort","type":"OTHER"},{"label":"Enrolled-06 Cohort","type":"NO_INTERVENTION"},{"label":"Enrolled-CU Cohort","type":"OTHER"}],"summary":"International, multicenter, long-term, follow-up study that will enrol HLH participants who have received emapalumab in previous clinical trials, in the context of the clinical development program for emapalumab or under compassionate use (CU).","primaryOutcome":{"measure":"Number of Participants With Adverse Event (AE)","timeFrame":"From the date of enrollment in this study up to 1 year either after HSCT or after the last administration of emapalumab (maximum duration: 639 days)","effectByArm":[{"arm":"Enrolled-04 Cohort","deltaMin":37,"sd":null},{"arm":"Enrolled-06 Cohort","deltaMin":12,"sd":null},{"arm":"Enrolled-CU Cohort","deltaMin":7,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":16,"countries":["United States","France","Italy","Spain","United Kingdom"]},"refs":{"pmids":["32374962","38662147","37001971"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":28,"n":37},"commonTop":["Pyrexia","Diarrhoea","Hypertension","Vomiting","Abdominal pain"]}}